Benke Geza, Turner Michelle C, Fleming Sarah, Figuerola Jordi, Kincl Laurel, Richardson Lesley, Blettner Maria, Hours Martine, Krewski Daniel, McLean David, Parent Marie-Elise, Sadetzki Siegal, Schlaefer Klaus, Schlehofer Brigitte, Siemiatycki Jack, van Tongeren Martie, Cardis Elisabeth
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne 3004, Australia.
Barcelona Institute for Global Health (ISGlobal), Barcelona 08036, Spain.
Br J Cancer. 2017 Oct 10;117(8):1246-1254. doi: 10.1038/bjc.2017.285. Epub 2017 Sep 14.
The aetiology of glioma remains largely unknown. Occupational solvent exposure has been suggested as a putative cause of glioma, but past studies have been inconsistent. We examined the association between a range of solvents and glioma risk within the INTEROCC project, a study of brain tumours and occupational exposures based on data from seven national case-control studies conducted in the framework of the INTERPHONE study. We also investigated associations according to tumour grade.
Data from the seven countries were standardised and then combined into one aggregate data set. Pooled odds ratios (ORs) were estimated for adjusted models that included sex, age, country-region of residence and level of educational attainment. Exposures to any solvent or 11 specific solvents or subgroups were assessed using a modified version of the FINJEM job exposure matrix (JEM) specifically developed for the study, called INTEROCC-JEM.
Analysis included 2000 glioma cases and 5565 controls. For glioma and ever/never exposure to any solvent, the OR was 0.91 (95% confidence interval: 0.74-1.11). All ORs were <1.0 for specific solvents/subgroups. There were no increases in risk according to high or low grade of tumour.
The results of this study show no consistent associations for any solvent exposures overall or by grade of tumour.
胶质瘤的病因在很大程度上仍然未知。职业性接触溶剂被认为是胶质瘤的一个假定病因,但过去的研究结果并不一致。我们在INTEROCC项目中研究了一系列溶剂与患胶质瘤风险之间的关联,该项目是一项基于在INTERPHONE研究框架内开展的七项全国性病例对照研究数据的脑肿瘤与职业暴露研究。我们还根据肿瘤分级调查了关联情况。
将七个国家的数据进行标准化处理,然后合并成一个汇总数据集。对纳入了性别、年龄、居住国家地区和教育程度水平的校正模型估计合并比值比(OR)。使用专门为该研究开发的FINJEM工作暴露矩阵(JEM)的修改版(称为INTEROCC-JEM)评估任何溶剂或11种特定溶剂或亚组的暴露情况。
分析纳入了2000例胶质瘤病例和5565例对照。对于胶质瘤以及曾经/从未接触任何溶剂,OR为0.91(95%置信区间:0.74 - 1.11)。特定溶剂/亚组的所有OR均<1.0。无论肿瘤分级高低,风险均未增加。
本研究结果表明,总体上或按肿瘤分级来看,任何溶剂暴露均无一致关联。